Association of accelerated phenotypic aging, genetic risk, and lifestyle with progression of type 2 diabetes: a prospective study using multi-state model.
Abstract
Aging is a major risk factor for type 2 diabetes (T2D), but individuals of the same chronological age may vary in their biological aging rate. The associations of Phenotypic Age Acceleration (PhenoAgeAccel), a new accelerated biological aging indicator based on clinical chemistry biomarkers, with the risk of dynamic progression remain unclear. We aimed to assess these associations and examine whether these associations varied by genetic risk and lifestyle.
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
The paper claims that accelerated phenotypic aging is associated with the progression of type 2 diabetes, influenced by genetic risk and lifestyle factors. This research is relevant as it explores the biological aging process and its implications for age-related diseases, contributing to the understanding of aging mechanisms rather than merely addressing symptoms.
Author of this paper? Send a correction.